(Q43068352)

13 November 2017

title

Measuring anxiety- and locomotion-related behaviours in mice: a new way of using old tests (English)

1 reference

13 November 2017

Leanne M Fraser

1

1 reference

13 November 2017

Richard E Brown

2

1 reference

13 November 2017

Ahmed Hussin

3

1 reference

13 November 2017

Mara Fontana

4

1 reference

13 November 2017

Ashley Whittaker

5

1 reference

13 November 2017

Timothy P O'Leary

6

1 reference

13 November 2017

Lauren Lederle

7

1 reference

13 November 2017

Andrew Holmes

8

1 reference

13 November 2017

André Ramos

9

1 reference

13 November 2017

publication date

8 May 2010

1 reference

13 November 2017

1 reference

13 November 2017

volume

211

1 reference

13 November 2017

issue

1

1 reference

13 November 2017

page(s)

99-112

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-010-1873-0

13 November 2017

exact match

0 references

cites work

Pharmacology of the beta-carboline FG-7,142, a partial inverse agonist at the benzodiazepine allosteric site of the GABA A receptor: neurochemical, neurophysiological, and behavioral effects.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-010-1873-0

The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-010-1873-0

The use of behavioral test batteries, II: effect of test interval.

21 January 2018

1 reference

12 December 2020

Animal models of behavioral dysfunctions: basic concepts and classifications, and an evaluation strategy

1 reference

12 December 2020

Common variations in the pretest environment influence genotypic comparisons in models of anxiety.

1 reference

12 December 2020

Strain differences in response to a benzodiazepine receptor inverse agonist (FG 7142) in mice

1 reference

12 December 2020

"One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?

1 reference

12 December 2020

Genetic relationship between anxiety-related and fear-related behaviors in BXD recombinant inbred mice

1 reference

12 December 2020

Animal models for the study of anti-anxiety agents: a review

1 reference

12 December 2020

Differences among nine 1,4-benzodiazepines: an ethopharmacological evaluation in mice

1 reference

12 December 2020

Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies

1 reference

12 December 2020

Effects of adolescent fluoxetine treatment on fear-, anxiety- or stress-related behaviors in C57BL/6J or BALB/cJ mice

1 reference

12 December 2020

Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze.

1 reference

12 December 2020

Effects of repeated maternal separation on anxiety- and depression-related phenotypes in different mouse strains

1 reference

12 December 2020

Genetic animal models of anxiety

1 reference

12 December 2020

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

12 December 2020

Stress and emotionality: a multidimensional and genetic approach

1 reference

12 December 2020

The discriminative stimulus effects of pentylenetetrazol as a model of anxiety: recent developments.

1 reference

12 December 2020

Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze.

1 reference

12 December 2020

Previous experience affects subsequent anxiety-like responses in rats bred for novelty seeking.

1 reference

12 December 2020

Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state?

1 reference

12 December 2020

Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice.

1 reference

12 December 2020

Absence of anxiolytic response to chlordiazepoxide in two common background strains exposed to the elevated plus-maze: importance and implications of behavioural baseline

1 reference

12 December 2020

Chronic benzodiazepine administration. IV. Rapid development of tolerance and receptor downregulation associated with alprazolam administration

1 reference

12 December 2020

Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic.

1 reference

12 December 2020

Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains

1 reference

12 December 2020

Stability of inbred mouse strain differences in behavior and brain size between laboratories and across decades

1 reference

12 December 2020

The ascent of mouse: advances in modelling human depression and anxiety

1 reference

12 December 2020

A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice

1 reference

12 December 2020

A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field

1 reference

12 December 2020

Measuring normal and pathological anxiety-like behaviour in mice: a review.

1 reference

12 December 2020

Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines

1 reference

12 December 2020

Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze

1 reference

12 December 2020

A genetic and multifactorial analysis of anxiety-related behaviours in Lewis and SHR intercrosses.

1 reference

12 December 2020

Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the disinhibition of open-arm avoidance.

1 reference

12 December 2020

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

1 reference

12 December 2020

Behavioral alterations induced by repeated testing in C57BL/6J and 129S2/Sv mice: implications for phenotyping screens.

1 reference

12 December 2020

Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models

1 reference

12 December 2020

Integrating the open field, elevated plus maze and light/dark box to assess different types of emotional behaviors in one single trial.

1 reference

12 December 2020

Sodium phenobarbitone reverses the anxiogenic effects of compounds acting at three different central sites

1 reference

12 December 2020

Psychogenic, neurogenic, and systemic stressor effects on plasma corticosterone and behavior: mouse strain-dependent outcomes

1 reference

12 December 2020

Genetics of mouse behavior: interactions with laboratory environment.

1 reference

12 December 2020

GABAergic influences on plus-maze behaviour in mice.

1 reference

12 December 2020

Differences in fear motivated behaviors among inbred mouse strains.

1 reference

12 December 2020

Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze

1 reference

12 December 2020

Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies.

1 reference

12 December 2020

Three murine anxiety models: results from multiple inbred strain comparisons

1 reference

12 December 2020

Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety.

1 reference

12 December 2020

Ethopharmacological analysis of rat behavior on the elevated plus-maze.

1 reference

12 December 2020

Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice.

1 reference

12 December 2020

Animal models of anxiety: do I need multiple tests?

1 reference

12 December 2020

The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review

1 reference

12 December 2020

One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze.

1 reference

12 December 2020

Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test.

1 reference

12 December 2020

Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on.

1 reference

12 December 2020

5HT drugs in animal models of anxiety

1 reference

12 December 2020

Ethologically-based animal models of anxiety disorders

1 reference

12 December 2020

Summary of a National Institute of Mental Health workshop: developing animal models of anxiety disorders.

1 reference

12 December 2020

10.1007/S00213-010-1873-0

Identifiers

DOI

1 reference

Dimensions Publication ID

13 November 2017

1043316197

0 references

1 reference